At a glance
Summary
Humana closed at $389.1 on 14 August, up 1.1% for the week and 26.6% over 12 weeks. The Healthcare Plans stock remains in an active weekly Trend Signal with an 11-week streak, trading 40.7% above its Trend Line and 25.5% above Sharemaestro Fair Value. The caution is participation: latest volume was 4.7M shares, only 0.7x the 13-week average, while activity pressure and relative strength remain positive but have cooled over four weeks.
- Humana’s latest close of $389.1 sits 85.1% through its 52-week range and 9.3% below the $428.9 high.
- The weekly Trend Signal is active for an 11th week, with price 40.7% above the $276.5 Trend Line.
- Momentum is mixed: +1.1% for the week and +26.6% over 12 weeks, but -2.7% over four weeks.
- Volume did not confirm the latest gain, with 4.7M shares versus a 13-week average of 6.8M and a 52-week average of 8.4M.
- Healthcare Plans breadth is strong, with 90.9% active trend signals and 72.7% positive relative strength, but Humana trailed the industry’s 1.7% weekly average.
Company analysis
The move in context
Price action stays constructive, but the recovery is no longer one-way
Humana ended the week at $389.1, adding 1.1% and keeping the stock in the upper part of its annual range. The close is 85.1% of the way from the 52-week low of $162.3 to the 52-week high of $428.9, leaving a 9.3% gap from that high-water mark. The longer recovery remains sizeable, with a 12-week gain of 26.6% and a 26-week move of 112.4%, but the recent four-week return of -2.7% shows the move has lost some short-term follow-through.
Trend Signal remains active while Market Dynamics cools
The Sharemaestro Trend Signal is active, and the streak has now reached 11 weeks. Price is 40.7% above the $276.5 Trend Line, which keeps the weekly regime constructive, while the 25.5% premium to Sharemaestro Fair Value of $310.1 shows investors are still paying up for the recovery. That premium can support confidence when momentum is expanding, but it also raises the importance of confirmation when the move pauses.
Sector and industry context is supportive, with some relative gaps
Humana’s Healthcare sector backdrop is broadly positive but uneven. US Healthcare averaged a 0.2% weekly gain, a 3.6% four-week gain and a 9.7% 12-week gain, with 57.0% of names in active weekly trends. Humana beat the sector on the week and over 12 weeks, but lagged the sector’s four-week performance. Relative strength across the sector is less broad, at 40.0%, making stock selection more important.
Healthcare Plans breadth is healthier than Humana’s latest week
Within US Healthcare Plans, the industry tone is stronger: 90.9% of stocks show active trend signals, while Market Dynamics and Relative Strength breadth both stand at 72.7%. Humana’s 1.1% weekly gain lagged the industry average of 1.7%, but its -2.7% four-week move was less weak than the group’s -4.7% average, and its 26.6% 12-week gain was well ahead of the 11.9% industry average. Oscar Health set a faster peer pace with a 17.4% week and 44.7% over 12 weeks, while Elevance gained 1.6% for the week and 7.3% over four weeks.
Volume and risk frame the next test
Participation was the main weak point. Latest volume of 4.7M shares was only 0.7x the 13-week average of 6.8M and 0.6x the 52-week average of 8.4M. That is lighter than the 7.2M shares behind the prior week’s 5.8% rebound and well below the 11.5M shares traded during the 31 July decline, so the latest advance did not carry strong volume confirmation. Market Dynamics remains positive at 0.55, and relative strength reads 28.22, but both have cooled over four weeks.
What to watch next
The next read is whether Humana can hold its active trend while rebuilding participation. A move closer to the 52-week high would be more convincing if volume rises above normal and activity pressure improves from its latest positive but softer reading. On the risk side, a valuation premium of 25.5% to Fair Value and a close still 40.7% above the Trend Line mean any loss of momentum could make the stock more sensitive to profit-taking, even though 13-week volatility of 5.5% is below the 52-week level of 7.1%.
Peer comparison
How the wider group is behaving
Breadth shows how much of the sector or industry is participating. A company move is more convincing when its peers are improving too.
US Healthcare
100 tracked companiesAbove Trend Line57.0%
Positive Relative Strength40.0%
US Healthcare Plans
11 tracked companiesAbove Trend Line90.9%
Positive Relative Strength72.7%
Balanced view
What supports the case, and what could weaken it
What is working
- The trend backdrop is active with a 11-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
- Activity pressure is constructive, supporting the smart-money activity read.
What needs caution
- No major top-level risk cluster is currently dominant.
Research note
This article is for educational market research only and is not financial, investment, trading, tax, or legal advice. Sharemaestro does not make buy, sell, or hold recommendations.
Source and attribution
Source: Sharemaestro. Canonical article: https://sharemaestro.com/news/humana-weekly-trend-signal-thin-volume-august-2026/.
Follow new Sharemaestro research through the RSS feed or JSON feed.